ESR1 and cancer: The ability of ER-positive breast cancers to grow, even in the presence of high levels of PPM1A suggests that in these cancers rely on other pathways, such as those stimulated by the estrogen and the estrogen receptor, support unregulated growth in ER-positive breast cancers.